drugset / Trial / NCT05777967
Efficacy and Safety of FF-31501 in Meniscus Tear Patients
NaSingle-groupOpen-labelTreatment
Summary
A single-arm, multi-center study to verify that knee joint function at 52 weeks after injection of FF-31501 is better than at screening in patients with meniscus tear who are eligible for meniscectomy .
Timeline
- Start
- 2023-01-01
- Primary completion
- 2024-12
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human autologous synovial stem cells | Cell therapy | 1.5e+07 cells | — |
| Subject | human autologous synovial stem cells | Cell therapy | 9e+07 cells | — |
Indications
No indication recorded.